Recombinant Human EEF1g Protein，His

EEF1G, or Elongation Factor 1 gamma, is a key protein involved in the protein synthesis process, specifically in the elongation phase of translation. As a member of the elongation factor family, EEF1G plays a critical role in facilitating the delivery of aminoacyl-tRNA to the ribosome, which is essential for the assembly of polypeptide chains during protein synthesis. Research on EEF1G has garnered significant attention due to its implications in various biological processes, including cell growth, proliferation, and stress response. Moreover, abnormal expression levels of EEF1G have been linked with several diseases, including cancer and neurodegenerative disorders, suggesting that it may serve as a potential biomarker for disease progression or a target for therapeutic interventions. The recombinant expression and characterization of EEF1G allow for a deeper understanding of its functional roles and regulatory mechanisms in cells. By utilizing recombinant DNA technology, researchers can produce EEF1G in sufficient quantities for detailed biochemical studies, enabling the exploration of its interaction with other protein factors and its contribution to the translational machinery. This research not only advances the fundamental knowledge of translation but also opens avenues for the development of novel strategies in the treatment of diseases associated with EEF1G dysregulation. Ultimately, the study of EEF1G and its recombinant forms promises to enhance our understanding of cellular processes and has potential implications in the fields of biotechnology and medicine.